Reduction of oxidative stress in liver cancer patients by oral green tea polyphenol tablets during hepatic arterial infusion chemotherapy

Baba,Yasutaka; Sonoda,Jun-Ichiro; Hayashi,Sadao; Tosuji,Nanako; Sonoda,Shunro; Makisumi,Kanro; Nakajo,Masayuki

doi:10.3892/etm.2012.602

Reduction of oxidative stress in liver cancer patients by oral green tea polyphenol tablets during hepatic arterial infusion chemotherapy

Authors:
- Yasutaka Baba
- Jun-Ichiro Sonoda
- Sadao Hayashi
- Nanako Tosuji
- Shunro Sonoda
- Kanro Makisumi
- Masayuki Nakajo
View Affiliations

Affiliations: Department of Radiology, Graduate School of Medical and Dental Sciences, Kagoshima University, Sakuragaoka, Kagoshima 890-8520, Japan
Published online on: June 7, 2012 https://doi.org/10.3892/etm.2012.602
Pages: 452-458

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hepatic arterial infusion chemotherapy (HAI) using an implanted port system is the standard regimen for primary and metastatic liver cancers (MLCs). However, there have been few studies concerning HAI-induced oxidative stress and damage to the liver or other organs. The aim of the present study was to investigate the ability of green tea polyphenols (GTPs) to reduce the oxidative stress or increase the biological antioxidative potential in HAI-treated patients. A total of 19 patients with inoperable hepatocellular carcinoma (HCC) or MLC from colorectal malignancy were eligible for HAI with cisplatin (CDDP) and 5‑fluorouracil (5FU). The study subjects were randomly assigned to either a 3 or a 6 oral GTP tablets per day group. Each tablet had a GTP content equivalent to 79 mg of epigallocatechin-3-gallate. The oxidative stress was assessed by measuring the levels of derivatives of reactive oxygen metabolites (d-ROMs) and the biological antioxidative potential (BAP) values in patient plasma using the Free Radical Analytical System 4 (FRAS4), and correlating the results with clinical laboratory data for the patients. The levels of d-ROMs were significantly reduced by the oral intake of 6 GTP tablets for 6‑9 months (P=0.0463) but were not significantly reduced by the oral intake of 3 GTP tablets daily. BAP values remained constant in the 3 and 6 tablet groups for 6‑9 months during the follow-up study. The total serum bilirubin (T-bil) levels increased significantly at 3 (P=0.028) and 9 (P=0.0151) months and the red blood cell (RBC) count decreased at 6 months (P=0.0458) after intake for the 6 GTP tablet group. Alkaline phosphatase (ALP) levels increased significantly at 9 months (P=0.0298). Cholinesterase (ChE) decreased significantly at 9 (P=0.0127) and 12 (P=0.0207) months after intake for the 3 GTP tablet group. The results indicate that the daily intake of 6 GTP tablets containing 474 mg polyphenols significantly reduces HAI-induced oxidative stress in HCC or MLC patients while the antioxidative potentials of the patients remain constant.

View Figures

View References

1.	Rice-Evans C: Implications of the mechanisms of action of tea polyphenols as antioxidants in vitro for chemoprevention in humans. Proc Soc Exp Biol Med. 220:262–266. 1999. View Article : Google Scholar : PubMed/NCBI
2.	Wiseman SA, Balentine DA and Frei B: Antioxidants in tea. Crit Rev Food Sci Nutr. 37:705–718. 1997. View Article : Google Scholar : PubMed/NCBI
3.	Muto S, Yokoi T, Gondo Y, et al: Inhibition of benzo[a]pyrene- induced mutagenesis by (-)-epigallocatechin gallate in the lung of rpsL transgenic mice. Carcinogenesis. 20:421–424. 1999.
4.	Yang GY, Liao J, Kim K, Yurkow EJ and Yang CS: Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis. 19:611–616. 1998. View Article : Google Scholar : PubMed/NCBI
5.	Okabe S, Ochiai Y, Aida M, et al: Mechanistic aspects of green tea as a cancer preventive: effect of components on human stomach cancer cell lines. Jpn J Cancer Res. 90:733–739. 1999. View Article : Google Scholar : PubMed/NCBI
6.	Setiawan VW, Zhang ZF, Yu GP, et al: Protective effect of green tea on the risks of chronic gastritis and stomach cancer. Int J Cancer. 92:600–604. 2001. View Article : Google Scholar : PubMed/NCBI
7.	Rao DN, Ganesh B, Dinshaw KA and Mohandas KM: A case- control study of stomach cancer in Mumbai, India. Int J Cancer. 99:727–731. 2002. View Article : Google Scholar : PubMed/NCBI
8.	Masuda M, Suzui M and Weinstein IB: Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin Cancer Res. 7:4220–4229. 2001.
9.	Masuda M, Suzui M, Lim JT and Weinstein IB: Epigallocatechin- 3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells. Clin Cancer Res. 9:3486–3491. 2003.PubMed/NCBI
10.	Liang YC, Lin-Shiau SY, Chen CF and Lin JK: Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells. J Cell Biochem. 67:55–65. 1997. View Article : Google Scholar : PubMed/NCBI
11.	Liang G, Tang A, Lin X, et al: Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer. Int J Oncol. 37:111–123. 2010.PubMed/NCBI
12.	Seki H, Ozaki T and Shiina M: Side-hole catheter placement for hepatic arterial infusion chemotherapy in patients with liver metastases from colorectal cancer: long-term treatment and survival benefit. AJR Am J Roentgenol. 190:111–120. 2008. View Article : Google Scholar : PubMed/NCBI
13.	Sonoda J, Koriyama C, Yamamoto S, et al: HTLV-1 provirus load in peripheral blood lymphocytes of HTLV-1 carriers is diminished by green tea drinking. Cancer Sci. 95:596–601. 2004. View Article : Google Scholar : PubMed/NCBI
14.	Mantovani G, Macciò A, Madeddu C, et al: Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress. J Mol Med (Berl). 81:664–673. 2003. View Article : Google Scholar
15.	Conklin KA: Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integr Cancer Ther. 3:294–300. 2004. View Article : Google Scholar : PubMed/NCBI
16.	Lamson DW and Brignall MS: Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Altern Med Rev. 4:304–329. 1999.PubMed/NCBI
17.	Quiles JL, Huertas JR, Battino M, Mataix J and Ramírez-Tortosa MC: Antioxidant nutrients and adriamycin toxicity (Review). Toxicology. 180:79–95. 2002. View Article : Google Scholar : PubMed/NCBI
18.	Moss RW: Should patients undergoing chemotherapy and radiotherapy be prescribed antioxidants? Integr Cancer Ther. 5:63–82. 2006. View Article : Google Scholar : PubMed/NCBI
19.	Lamson DW and Brignall MS: Antioxidants and cancer, part 3: quercetin. Altern Med Rev. 5:196–208. 2000.PubMed/NCBI
20.	Lamson DW and Brignall MS: Antioxidants and cancer therapy II: quick reference guide. Altern Med Rev. 5:152–163. 2000.PubMed/NCBI
21.	Lamson DW and Brignall MS: Natural agents in the prevention of cancer. Part 1: human chemoprevention trials. Altern Med Rev. 6:7–19. 2001.PubMed/NCBI
22.	Pathak AK, Bhutani M, Guleria R, et al: Chemotherapy alone vs. chemotherapy plus high dose multiple antioxidants in patients with advanced non small cell lung cancer. J Am Coll Nutr. 24:16–21. 2005. View Article : Google Scholar : PubMed/NCBI
23.	Pathak AK, Singh N, Khanna N, Reddy VG, Prasad KN and Kochupillai V: Potentiation of the effect of paclitaxel and carboplatin by antioxidant mixture on human lung cancer h520 cells. J Am Coll Nutr. 21:416–421. 2002. View Article : Google Scholar : PubMed/NCBI
24.	Drisko JA, Chapman J and Hunter VJ: The use of antioxidant therapies during chemotherapy (Review). Gynecol Oncol. 88:434–439. 2003. View Article : Google Scholar : PubMed/NCBI
25.	Kanaoka Y, Inagaki E, Hamanaka S, Masaki H and Tanemoto K: Analysis of reactive oxygen metabolites (ROMs) after cardiovascular surgery as a marker of oxidative stress. Acta Med Okayama. 64:323–330. 2010.PubMed/NCBI
26.	Cesarone MR, Belcaro G, Carratelli M, et al: A simple test to monitor oxidative stress. Int Angiol. 18:127–130. 1999.
27.	Nakayama K, Terawaki H, Nakayama M, Iwabuchi M, Sato T and Ito S: Reduction of serum antioxidative capacity during hemodialysis. Clin Exp Nephrol. 11:218–224. 2007. View Article : Google Scholar : PubMed/NCBI
28.	Kono S, Ikeda M, Tokudome S and Kuratsune M: A case-control study of gastric cancer and diet in northern Kyushu, Japan. Jpn J Cancer Res. 79:1067–1074. 1988. View Article : Google Scholar : PubMed/NCBI
29.	Ohno Y, Wakai K, Genka K, et al: Tea consumption and lung cancer risk: a case-control study in Okinawa, Japan. Jpn J Cancer Res. 86:1027–1034. 1995. View Article : Google Scholar : PubMed/NCBI
30.	Imai K, Suga K and Nakachi K: Cancer-preventive effects of drinking green tea among a Japanese population. Prev Med. 26:769–775. 1997. View Article : Google Scholar : PubMed/NCBI
31.	Kimura M, Umegaki K, Kasuya Y, Sugisawa A and Higuchi M: The relation between single/double or repeated tea catechin ingestions and plasma antioxidant activity in humans. Eur J Clin Nutr. 56:1186–1193. 2002. View Article : Google Scholar : PubMed/NCBI
32.	Koren E, Kohen R and Ginsburg I: Polyphenols enhance total oxidant-scavenging capacities of human blood by binding to red blood cells. Exp Biol Med (Maywood). 235:689–699. 2010. View Article : Google Scholar : PubMed/NCBI